100 HLA-identical sibling transplants. Prognostic factors other than histocompatibility. 1979

N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian

Analysis of 100 patients receiving HLA identical sibling transplants was performed. Excellent graft survival demonstrated in the group attests to the importance of matching serological determined antigens. There seems to be a modest beneficial effect on antilymphoblast globulin in low dosage, but not in high doses. Insulin dependent diabetes mellitus results in a significant negative influence on patient survival and graft function in the male recipient but not in the female. A particularly striking point that emerges is the potential hazard in incorrectly treating for rejection. Rejection occurs very rarely in these patients; in a patient with deteriorating renal function, etiologies other than rejection should be vigorously sought (including transcutaneous biopsy) prior to initiation of rejection therapy.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009026 Mortality All deaths reported in a given population. CFR Case Fatality Rate,Crude Death Rate,Crude Mortality Rate,Death Rate,Age Specific Death Rate,Age-Specific Death Rate,Case Fatality Rate,Decline, Mortality,Determinants, Mortality,Differential Mortality,Excess Mortality,Mortality Decline,Mortality Determinants,Mortality Rate,Mortality, Differential,Mortality, Excess,Age-Specific Death Rates,Case Fatality Rates,Crude Death Rates,Crude Mortality Rates,Death Rate, Age-Specific,Death Rate, Crude,Death Rates,Determinant, Mortality,Differential Mortalities,Excess Mortalities,Mortalities,Mortality Declines,Mortality Determinant,Mortality Rate, Crude,Mortality Rates,Rate, Age-Specific Death,Rate, Case Fatality,Rate, Crude Death,Rate, Crude Mortality,Rate, Death,Rate, Mortality,Rates, Case Fatality
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
April 1992, Bone marrow transplantation,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
October 1994, Transplantation proceedings,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
October 1999, Bone marrow transplantation,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
January 1991, Bone marrow transplantation,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
December 1992, Transplantation proceedings,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
September 1998, Blood,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
January 1989, Progress in clinical and biological research,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
January 1996, Bone marrow transplantation,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
May 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
N L Ascher, and R L Simmons, and H Noreen, and J VanHook, and R J Howard, and D E Sutherland, and J S Najarian
October 1979, The American journal of medicine,
Copied contents to your clipboard!